ARA to Showcase Disruptive Technologies at “Creative Disruptors in the Desert” Conference

La Quinta, CA, Feb. 10, 2025 (GLOBE NEWSWIRE) — Applied Research Associates, Inc. (ARA) is a proud sponsor and exhibitor at the upcoming Creative Disruptors in the Desert conference, hosted by The Creative Defense Foundation February 21-22, 2025, in La Quinta, CA. Creative Disruptors in the Desert will bring together legislative and national security leaders, […]

Qu Biologics’ Immunomodulator Clears Senescence

BURNABY, British Columbia, Feb. 10, 2025 (GLOBE NEWSWIRE) — Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation platform designed to restore innate immune function, is pleased to report exciting data demonstrating that its QBECO immunomodulator lowers a key indicator of senescence in the liver of animals with

Recludix Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) — Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D., its president and chief executive officer, and Ajay Nirula, M.D., Ph.D., its executive vice president and head of research and development, will present an overview of

AtmosZero Opens New Factory in Colorado to Deliver Decarbonized Steam Globally

LOVELAND, Colo., Feb. 10, 2025 (GLOBE NEWSWIRE) — AtmosZero, the company on a mission to electrify steam, has opened its first 100,000 square-foot manufacturing factory at the Forge Campus in Loveland, Colorado. This new factory is the first step to commercializing Boiler 2.0 and the company's expansion of its manufacturing footprint to support upwards of

Oxford Lane Capital Corp. Provides January Net Asset Value Update

(NASDAQ:OXLCO),(NasdaqGM:OXLC),(NASDAQ:OXLCP),(NASDAQ:OXLCL),(NASDAQ:OXLCZ),(NASDAQ:OXLCN),(NASDAQ:OXLCI), GREENWICH, Conn., Feb. 10, 2025 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (the “Company”) today announced the following net asset value (“NAV”) estimate as of January 31, 2025. Management's unaudited estimate of the range of the NAV per share of

Dillard’s to Donate more than $250,000 to local RMHC Chapters through sale of Southern Living Christmas Cookbook

(NYSE:DDS), LITTLE ROCK, Ark., Feb. 10, 2025 (GLOBE NEWSWIRE) — Dillard's, Inc. (DDS: NYSE, “Dillard's”) announced today that it will make a significant contribution of more than $250,000 to local Ronald McDonald House Charities (RMHC) Chapters. This donation was made possible through the sale of Dillard's exclusive Southern Living Christmas Cookbook. Dillard's offered a special

Wartsila introduces next-generation engine to balance renewables and improve power plant performance

HOUSTON, Feb. 10, 2025 (GLOBE NEWSWIRE) — Technology group Wartsila launches today its next generation 46TS engine, which is designed to balance renewable energy, provide highly efficient baseload power, and can run on sustainable fuels in future. The Wartsila 46TS large-bore engine has evolved from a long line of proven and reliable power plant engines,

D. Boral Capital Served as Co-placement Agent to MicroVision, Inc. (Nasdaq: MVIS) in Connection with its up to $17.0 Million Private Placement

(NasdaqGM:MVIS), NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) — MicroVision, Inc. (NASDAQ:MVIS), a leader in MEMS-based solid-state automotive lidar and ADAS solutions, today announced that it has bolstered its financial position by entering into an agreement to raise up to $17 million in new capital and reducing future cash obligations stemming from its $75 million

Prosper Gold Mobilizes Crews to Cyprus Project in Preparation for Diamond Drilling

(TSX-V:PGX),(OTC US:PGXFF),(Other OTC:PGXFF), VANCOUVER, British Columbia, Feb. 10, 2025 (GLOBE NEWSWIRE) — Prosper Gold Corp. (“Prosper Gold” or the “Company“) (TSXV:PGX) reports that crews and equipment have been mobilized to the Company's Cyprus Project in north-central British Columbia, Canada, to prepare access trails and drill pads for a diamond drilling program to be completed over

Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis

(NASDAQ:POAI), Study used Predictive Oncology's vast biobank of cryopreserved live cell tumor specimens for the production and testing of primary patient tumor spheroids Results presented at the 2025 Society for Laboratory Automation and Screening (SLAS) PITTSBURGH, Feb. 10, 2025 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics,

Scroll to Top